Multicenter examination showed biomarkers in cerebrospinal fluid consistently distinguished MS from other ...

Getting to the bottom of the cause in this 29-year-old woman illustrates the diagnostic co ...

Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...

Guillain-Barré Syndrome Presenting as Pseudo-Cerebellar Syndrome: A Case Report from a Resource-Limited Setting in Sub-Saharan Africa Guillain-Barré Syndrome (GBS) is the most frequent cause of acute ...

The Information Technology Industry Council is encouraging the National Institute of Standards and Technology to provide more ...

Data represents up to 8.5 years of follow-up and are consistent across age, dose, and genotypeBLA resubmitted to U.S. FDA in January 2026; ...

In January 2026, Digital Realty Trust confirmed its entry into Malaysia by agreeing to acquire CSF Advisers, owner of the ...

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple ...

Data represents up to 8.5 years of follow-up and are consistent across age, dose, and genotype BLA resubmitted to U.S. FDA in January 2026; Company expects up to six-month review period per FDA guidel ...

DelveInsight's Oncolytic Virus Competitive Landscape 2026 report provides comprehensive global coverage of pipeline oncolytic ...

BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...

Expanded NIS 2 coverage for Croatia and Belgium reinforces Cynomi’s leadership in scalable security and compliance governance ...